Ausgabe 2/2010
Inhalt (18 Artikel)
A human brainstem glioma xenograft model enabled for bioluminescence imaging
Rintaro Hashizume, Tomoko Ozawa, Eduard B. Dinca, Anuradha Banerjee, Michael D. Prados, Charles D. James, Nalin Gupta
The frequency of NBN molecular variants in pediatric astrocytic tumors
Dorota Piekutowska-Abramczuk, Elżbieta Ciara, Ewa Popowska, Wiesława Grajkowska, Bożenna Dembowska-Bagińska, Ewa Kowalewska, Aneta Czajńska, Marta Perek-Polnik, Marcin Roszkowski, Małgorzata Syczewska, Małgorzata Krajewska-Walasek, Danuta Perek, Krystyna H. Chrzanowska
A survey of glioblastoma genomic amplifications and deletions
Shailaja K. Rao, Jennifer Edwards, Avadhut D. Joshi, I-Mei Siu, Gregory J. Riggins
The invasiveness of five medulloblastoma cell lines in collagen gels
Adrianna Ranger, Warren McDonald, Emi Moore, Rolando DelMaestro
PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A
Yi-Hong Zhou, Yuanjie Hu, Debra Mayes, Eric Siegel, Jae G. Kim, Marlon S. Mathews, Nelson Hsu, Daniel Eskander, Ong Yu, Bruce J. Tromberg, Mark E. Linskey
Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide
Nicholas A. Pullen, Helen L. Fillmore
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Andrew D. Norden, Jeffrey J. Raizer, Lauren E. Abrey, Kathleen R. Lamborn, Andrew B. Lassman, Susan M. Chang, W. K. Alfred Yung, Mark R. Gilbert, Howard A. Fine, Minesh Mehta, Lisa M. DeAngelis, Timothy F. Cloughesy, H. Ian Robins, Kenneth Aldape, Janet Dancey, Michael D. Prados, Frank Lieberman, Patrick Y. Wen
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
David A. Reardon, Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, James E. Herndon II, Jennifer Marcello, Julie A. Norfleet, Roger E. McLendon, John H. Sampson, Henry S. Friedman
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors
Norbert Galldiks, Lutz W. Kracht, Frank Berthold, Hrvoje Miletic, Johannes C. Klein, Karl Herholz, Andreas H. Jacobs, Wolf-Dieter Heiss
Information gaps for patients requiring craniotomy for benign brain lesion: a qualitative study
Linda Rozmovits, Kathleen Joy Khu, Soha Osman, Fred Gentili, Abhijit Guha, Mark Bernstein
Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
J. A. B. van Genugten, P. Leffers, B. G. Baumert, H. Tjon-a-Fat, A. Twijnstra
Salvage therapy with single agent bevacizumab for recurrent glioblastoma
Marc C. Chamberlain, Sandra K. Johnston
Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials
Sarah K. Lageman, Jane H. Cerhan, Dona E. C. Locke, S. Keith Anderson, Wenting Wu, Paul D. Brown
Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma
H. Quon, A. Hasbini, J. Cougnard, L. Djafari, C. Lacroix, B. Abdulkarim
Intradural clival chordoma: a rare pathological entity
D. I. Bhat, M. Yasha, A. Rojin, S. Sampath, S. K. Shankar
Intraventricular gliosarcoma: unusual location of an uncommon tumor
Aliasgar Moiyadi, Epari Sridhar, Rakesh Jalali
Late spinal cord metastasis of fourth ventricle ependymoma appeared nineteen years after the initial treatment
Hidenobu Ochiai, Yuzo Yamakawa, Hirokazu Kawano, Yoshiya Shimao, Tohru Hayashi